Predictors of influenza vaccination among elderly: a cross-sectional survey in Greece.


Journal

Aging clinical and experimental research
ISSN: 1720-8319
Titre abrégé: Aging Clin Exp Res
Pays: Germany
ID NLM: 101132995

Informations de publication

Date de publication:
Sep 2020
Historique:
received: 08 08 2019
accepted: 21 09 2019
pubmed: 14 10 2019
medline: 1 12 2020
entrez: 14 10 2019
Statut: ppublish

Résumé

Senior individuals are particularly vulnerable to influenza. Research suggests that protection against the virus and its transmission in this high-risk group of the population can be achieved by active immunization against the pathogen. To explore and analyze the attitudes, knowledge and behavior of people over the age of 60 on influenza vaccination. This cross-sectional survey included people over the age of 60 who were eligible candidates for the influenza vaccine from 3 regions from Northern and 1 region from Southern Greece. A self-completed questionnaire based upon the Theory of Planned Behaviour, the Motivation for Vaccination (MoVac-flu) and the Vaccination Advocacy Scale (MovAd) was administered to the participants. Demographic characteristics and information about health status were also obtained. The final sample included 318 participants with mean age of 70.7 years. More than half of the participants (56.6%) had received a flu vaccine in 2018 while 50.8% received it annually in previous years. Behavioral (p < 0.001), normative (p < 0.001), and control beliefs (p < 0.001), promoted the uptake of the vaccine and the increased intention score (p < 0.001) was associated with increased probability of vaccination. Greater age (p = 0.001) and frequent visits to the doctors (p = 0.003) had a positive influence upon the uptake of the vaccine. Only a small proportion of those over the age of 60 had received the influenza vaccine. This finding is worrying, as it indicates the impact that a future outbreak of seasonal influenza could exert upon vulnerable groups. There is an urgent need for further, better and more evidence-based information from healthcare professionals to achieve greater vaccination coverage in the community.

Sections du résumé

BACKGROUND BACKGROUND
Senior individuals are particularly vulnerable to influenza. Research suggests that protection against the virus and its transmission in this high-risk group of the population can be achieved by active immunization against the pathogen.
AIMS OBJECTIVE
To explore and analyze the attitudes, knowledge and behavior of people over the age of 60 on influenza vaccination.
POPULATION AND METHODS METHODS
This cross-sectional survey included people over the age of 60 who were eligible candidates for the influenza vaccine from 3 regions from Northern and 1 region from Southern Greece. A self-completed questionnaire based upon the Theory of Planned Behaviour, the Motivation for Vaccination (MoVac-flu) and the Vaccination Advocacy Scale (MovAd) was administered to the participants. Demographic characteristics and information about health status were also obtained.
RESULTS RESULTS
The final sample included 318 participants with mean age of 70.7 years. More than half of the participants (56.6%) had received a flu vaccine in 2018 while 50.8% received it annually in previous years. Behavioral (p < 0.001), normative (p < 0.001), and control beliefs (p < 0.001), promoted the uptake of the vaccine and the increased intention score (p < 0.001) was associated with increased probability of vaccination. Greater age (p = 0.001) and frequent visits to the doctors (p = 0.003) had a positive influence upon the uptake of the vaccine.
CONCLUSIONS CONCLUSIONS
Only a small proportion of those over the age of 60 had received the influenza vaccine. This finding is worrying, as it indicates the impact that a future outbreak of seasonal influenza could exert upon vulnerable groups. There is an urgent need for further, better and more evidence-based information from healthcare professionals to achieve greater vaccination coverage in the community.

Identifiants

pubmed: 31606859
doi: 10.1007/s40520-019-01367-4
pii: 10.1007/s40520-019-01367-4
doi:

Substances chimiques

Influenza Vaccines 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1821-1828

Références

Prevention, C.f.D.C.a. (2018) Past pandemics. August 10, 2018; https://www.cdc.gov/flu/pandemic-resources/basics/past-pandemics.html
Kostova D, Reed C, Finelli L et al (2013) Influenza illness and hospitalizations averted by influenza vaccination in the United States, 2005–2011. PLoS One 8(6):e66312
pubmed: 23840439 pmcid: 3686813 doi: 10.1371/journal.pone.0066312
Prevention, C.f.D.C.a (2018) People 65 years and older & influenza. December 10, 2018. https://www.cdc.gov/flu/about/disease/65over.html
Healthline (2018) Flu in older adults: symptoms, complications, and more. September 11, 2018. https://www.healthline.com/health/flu/flu-in-elderly-symptoms-complications
Postma MJ, Baltussen RP, Palache AM et al (2006) Further evidence for favorable cost-effectiveness of elderly influenza vaccination. Expert Rev Pharmacoecon Outcomes Res 6:215–227
pubmed: 20528557 doi: 10.1586/14737167.6.2.215
Jit M, Newall AT, Beutels P (2013) Key issues for estimating the impact and cost-effectiveness of seasonal influenza vaccination strategies. Hum Vaccines Immunother 9:834–840
doi: 10.4161/hv.23637
European Centre for Disease Prevention and Control (2017) Seasonal influenza vaccination in Europe. Vaccination recommendations and coverage rates in the EU Member States for eight influenza seasons: 2007–2008 to 2014–2015. ECDC, Stockholm
de Lusignan S, Correa A, Ellis J, Pebody R (2016) Influenza vaccination: in the UK and across. Europe
Ajzen I, Fishbein M (1988) Theory of reasoned action-Theory of planned behavior. University of South Florida
Schmid P, Rauber D, Betsch C et al (2017) Barriers of influenza vaccination intention and behavior—a systematic review of influenza vaccine hesitancy, 2005–2016. PloS One 12(1):e0170550
pubmed: 28125629 pmcid: 5268454 doi: 10.1371/journal.pone.0170550
Hausenblas HA, Carron AV, Mack DE (1997) Application of the theories of reasoned action and planned behavior to exercise behavior: a meta-analysis. J Sport Exerc Psychol 19:36–51
doi: 10.1123/jsep.19.1.36
López-De-Andrés A, Carrasco-Garrido P, Hernández-Barrera V et al (2007) Coverages and factors associated with influenza vaccination among subjects with chronic respiratory diseases in Spain. Eur J Pub Health 18:173–177
doi: 10.1093/eurpub/ckm093
Wooten KG, Wortley PM, Singleton JA et al (2012) Perceptions matter: beliefs about influenza vaccine and vaccination behavior among elderly white, black and Hispanic Americans. Vaccine 30:6927–6934
pubmed: 22939908 doi: 10.1016/j.vaccine.2012.08.036
Xakellis GC (2005) Predictors of influenza immunization in persons over age 65. J Am Board Family Pract 18:426–433
doi: 10.3122/jabfm.18.5.426
Nagata JM, Hernández-Ramos I, Kurup AS et al (2013) Social determinants of health and seasonal influenza vaccination in adults ≥ 65 years: a systematic review of qualitative and quantitative data. BMC Public Health 13:388
pubmed: 23617788 pmcid: 3667118 doi: 10.1186/1471-2458-13-388
Piccirillo B, Gaeta T (2006) Survey on use of and attitudes toward influenza vaccination among emergency department staff in a New York metropolitan hospital. Infect Control Hosp Epidemiol 27:618–622
pubmed: 16755483 doi: 10.1086/504448
Vallee-Tourangeau G (2016) Levels of engagement with vaccination impacts risk perception and vaccination-decisions in healthcare workers. In: Strategies to increase vaccine acceptance and uptake; 26–28 Sep 2016, Les Pensières, Annecy, France (Unpublished)
Vallée-Tourangeau G, Promberger M, Moon K et al (2018) Motors of influenza vaccination uptake and vaccination advocacy in healthcare workers: development and validation of two short scales. Vaccine 36:6540–6545
pubmed: 28958815 doi: 10.1016/j.vaccine.2017.08.025
Jakubowski E (1998) Health care systems in the EU: a comparative study. European Parliament. Public Health and Consumer Protection Series SACO 101 PE 167.403
Beaton DE, Bombardier C, Guillemin F et al (2000) Guidelines for the process of cross-cultural adaptation of self-report measures. Spine 25:3186–3191
doi: 10.1097/00007632-200012150-00014
Joseph C, Goddard G, Gelb D (2005) Influenza vaccine uptake and distribution in England and Wales using data from the General Practice Research Database, 1989/90–2003/04. J Public Health 27:371–377
doi: 10.1093/pubmed/fdi054
Plans-Rubió P (2012) The vaccination coverage required to establish herd immunity against influenza viruses. Prev Med 55:72–77
pubmed: 22414740 doi: 10.1016/j.ypmed.2012.02.015
Sintes X, Nebot M, Izquierdo C et al (2011) Factors associated with pneumococcal and influenza vaccination in hospitalized people aged 65 years. Epidemiol Infection 139:666–673
doi: 10.1017/S0950268810001846
Hebert PL, Frick KD, Kane RL et al (2005) The causes of racial and ethnic differences in influenza vaccination rates among elderly Medicare beneficiaries. Health Serv Res 40:517–538
pubmed: 15762905 pmcid: 1361154 doi: 10.1111/j.1475-6773.2005.0e371.x
Bödeker B, Remschmidt C, Schmich P et al (2015) Why are older adults and individuals with underlying chronic diseases in Germany not vaccinated against flu? A population-based study. BMC Public Health 15:618
pubmed: 26148480
Kumar S, Quinn SC, Kim KH et al (2012) The social ecological model as a framework for determinants of 2009 H1N1 influenza vaccine uptake in the United States. Health Educ Behav 39:229–243
pubmed: 21984692 doi: 10.1177/1090198111415105
Lau L, Lau Y, Lau YH (2009) Prevalence and correlates of influenza vaccination among non-institutionalized elderly people: an exploratory cross-sectional survey. Int J Nurs Stud 46:768–777
pubmed: 19162264 pmcid: 7094414 doi: 10.1016/j.ijnurstu.2008.12.006
Myers LB, Goodwin R (2011) Determinants of adults’ intention to vaccinate against pandemic swine flu. BMC Public Health 11:15
pubmed: 21211000 pmcid: 3024930 doi: 10.1186/1471-2458-11-15
Kee SY, Lee JS, Cheong HJ et al (2007) Influenza vaccine coverage rates and perceptions on vaccination in South Korea. J Infect 55:273–281
pubmed: 17602750 pmcid: 7132372 doi: 10.1016/j.jinf.2007.04.354
Chiatti C, Barbadoro P, Lamura G et al (2011) Influenza vaccine uptake among community-dwelling Italian elderly: results from a large cross-sectional study. BMC Public Health 11:207
pubmed: 21457562 pmcid: 3078885 doi: 10.1186/1471-2458-11-207
Horby PW, Williams A, Burgess MA et al (2005) Prevalence and determinants of influenza vaccination in Australians aged 40 years and over—a national survey. Aust N Z J Public Health 29:35–37
pubmed: 15782869 doi: 10.1111/j.1467-842X.2005.tb00745.x
Dyda A, MacIntyre CR, McIntyre P et al (2015) Factors associated with influenza vaccination in middle and older aged Australian adults according to eligibility for the national vaccination program. Vaccine 33:3299–3305
pubmed: 26036944 doi: 10.1016/j.vaccine.2015.05.046
Mamelund SE, Bergsaker MAR (2011) Vaccine history, gender and influenza vaccination in a household context. Vaccine 29:9441–9450
pubmed: 22027482 doi: 10.1016/j.vaccine.2011.10.035
Sammon CJ, McGrogan A, Snowball J et al (2012) Factors associated with uptake of seasonal and pandemic influenza vaccine among clinical risk groups in the UK: an analysis using the General Practice Research Database. Vaccine 30:2483–2489
pubmed: 22133511 doi: 10.1016/j.vaccine.2011.11.077
Lopez-de-Andres A, Carrasco-Garrido P, Hernandez-Barrera V et al (2008) Coverages and factors associated with influenza vaccination among subjects with chronic respiratory diseases in Spain. Eur J Public Health 18:173–177
pubmed: 17875577 doi: 10.1093/eurpub/ckm093
Barbadoro P, Marigliano A, Di Tondo E et al (2013) Determinants of influenza vaccination uptake among Italian healthcare workers. Hum Vaccines Immunother 9:911–916
doi: 10.4161/hv.22997

Auteurs

Ioannis Dardalas (I)

Department of Clinical Pharmacology, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, University Campus, 54124, Thessaloníki, Greece.

Chryssa Pourzitaki (C)

Department of Clinical Pharmacology, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, University Campus, 54124, Thessaloníki, Greece. chpour@gmail.com.

Georgios Manomenidis (G)

General Hospital of Ptolemaida, 50200, Ptolemaida, Kozani, Greece.

Faye Malliou (F)

Department of Clinical Pharmacology, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, University Campus, 54124, Thessaloníki, Greece.

Petros Galanis (P)

Center for Health Services Management and Evaluation, Faculty of Nursing, Kapodistrian University of Athens, Athens, Greece.

Georgios Papazisis (G)

Department of Clinical Pharmacology, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, University Campus, 54124, Thessaloníki, Greece.

Dimitrios Kouvelas (D)

Department of Clinical Pharmacology, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, University Campus, 54124, Thessaloníki, Greece.

Thalia Bellali (T)

Faculty of Nursing, "Alexander" Technological Educational Institute of Thessaloniki, Thessaloníki, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH